Page last updated: 2024-09-03

desacetylnantradol and sr141716

desacetylnantradol has been researched along with sr141716 in 2 studies

Compound Research Comparison

Studies (desacetylnantradol)	Trials (desacetylnantradol)	Recent Studies (post-2010) (desacetylnantradol)	Studies (sr141716)	Trials (sr141716)	Recent Studies (post-2010) (sr141716)
18	0	0	2,229	60	631

Protein Interaction Comparison

Protein	Taxonomy	sr141716 (IC50)
Bile salt export pump	Homo sapiens (human)	10
Cytochrome P450 3A4	Homo sapiens (human)	0.0069
Cannabinoid receptor 1	Rattus norvegicus (Norway rat)	0.0081
Cannabinoid receptor 1	Homo sapiens (human)	0.0219
Cytochrome P450 2C19	Homo sapiens (human)	0.0069
Cannabinoid receptor 2	Homo sapiens (human)	2.4666
Cannabinoid receptor 1	Mus musculus (house mouse)	0.025
Mu-type opioid receptor	Cavia porcellus (domestic guinea pig)	0.108
Potassium voltage-gated channel subfamily H member 2	Homo sapiens (human)	3.795

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Houston, DB; Howlett, AC	1
Gafni, M; Rubovitch, V; Sarne, Y	1

Other Studies

2 other study(ies) available for desacetylnantradol and sr141716

Article	Year
Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists. Cellular signalling, 1998, Volume: 10, Issue:9 Topics: Animals; Benzoxazines; Binding Sites; Binding, Competitive; Brain; Cannabinoids; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Morpholines; Naphthalenes; Phenanthridines; Piperidines; Pyrazoles; Radioligand Assay; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sodium	1998
The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells. Brain research. Molecular brain research, 2002, May-30, Volume: 101, Issue:1-2 Topics: Adenylyl Cyclases; Analgesics; Animals; Calcium; Calcium Channels, L-Type; Calcium Signaling; Calmodulin; Cannabinoids; Central Nervous System; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Membrane Potentials; Neuroblastoma; Pertussis Toxin; Phenanthridines; Piperidines; Protein Kinase C; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sodium Channels; Tumor Cells, Cultured; Virulence Factors, Bordetella	2002

Article

Year

Differential receptor-G-protein coupling evoked by dissimilar cannabinoid receptor agonists.

Cellular signalling, 1998, Volume: 10, Issue:9

Topics: Animals; Benzoxazines; Binding Sites; Binding, Competitive; Brain; Cannabinoids; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Morpholines; Naphthalenes; Phenanthridines; Piperidines; Pyrazoles; Radioligand Assay; Rats; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sodium

1998

The cannabinoid agonist DALN positively modulates L-type voltage-dependent calcium-channels in N18TG2 neuroblastoma cells.

Brain research. Molecular brain research, 2002, May-30, Volume: 101, Issue:1-2

Topics: Adenylyl Cyclases; Analgesics; Animals; Calcium; Calcium Channels, L-Type; Calcium Signaling; Calmodulin; Cannabinoids; Central Nervous System; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Membrane Potentials; Neuroblastoma; Pertussis Toxin; Phenanthridines; Piperidines; Protein Kinase C; Pyrazoles; Receptors, Cannabinoid; Receptors, Drug; Rimonabant; Sodium Channels; Tumor Cells, Cultured; Virulence Factors, Bordetella

2002